Context Therapeutics Inc.

NASDAQ: CNTX · Real-Time Price · USD
0.73
0.03 (4.29%)
At close: Aug 14, 2025, 3:52 PM
0.75
2.81%
Pre-market: Aug 15, 2025, 08:45 AM EDT

Context Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a 18.95K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
4.07K n/a n/a n/a n/a n/a 2.57K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-4.07K n/a n/a n/a -2.57K -2.57K 16.38K -3.09K -3.19K -3.19K n/a -3.19K n/a n/a n/a n/a n/a n/a
Operating Income
-9.76M -5.53M -4.31M -18.7M -3.09M -3.82M -6.93M -6.18M -5.29M -6.67M -3.88M -4.05M -4.01M -3.44M -3.09M -1.57M -5.03M -840K
Interest Income
903.77K 958.52K 964.04K 1.24M 840.15K 152.35K 224.72K 290.44K 293.27K 355.54K n/a 192.25K 21.3K 5.86K n/a n/a n/a n/a
Pretax Income
-8.83M -4.58M -3.34M -17.46M -2.25M -3.67M -6.77M -5.88M -5.01M -6.31M -3.56M -3.85M -3.99M -3.44M -3.09M -1.44M -5.03M -892K
Net Income
-8.83M -4.58M -3.34M -17.46M -2.25M -3.67M -6.77M -5.88M -5.01M -6.31M -3.56M -3.85M -3.99M -3.44M -3.09M -1.44M -5.03M -892K
Selling & General & Admin
1.92M 2.07M 1.79M 1.88M 1.7M 1.85M 1.63M 1.7M 1.83M 2.13M 1.74M 1.97M 1.99M 2.09M 1.8M 828.46K 604.6K 401.58K
Research & Development
7.83M 3.46M 2.52M 16.82M 1.39M 1.97M 5.3M 4.49M 3.46M 4.54M 2.15M 2.08M 1.52M 1.35M 1.29M 739.6K 1.33M 438.74K
Other Expenses
n/a n/a 2.75K n/a -6.11K 3.35K -61.4K 15.37K -12.23K 2.69K n/a 1.53K 500K -1.24K -276 n/a 3.09M 1.94K
Operating Expenses
9.75M 5.53M 4.31M 18.7M 3.09M 3.82M 6.93M 6.18M 5.29M 6.67M 3.88M 4.05M 4.01M 3.44M 3.09M 1.57M 5.03M 840.32K
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.26K 309.00 62.98K
Selling & Marketing Expenses
n/a n/a n/a n/a -2.57K -2.57K -2.57K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
9.76M 5.53M 4.32M 18.7M 3.09M 3.82M 6.93M 6.18M 5.29M 6.67M 3.88M 4.05M 4.01M 3.44M 3.09M 1.57M 5.03M 840.32K
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -21.3K -10.49K n/a 1.26K n/a n/a
Shares Outstanding (Basic)
95.19M 95.19M 58.42M 80.48M 54.96M 15.97M 15.97M 15.97M 15.97M 15.97M 15.97M 15.97M 15.97M 15.97M 10.21M 361K 6.88M 10.21M
Shares Outstanding (Diluted)
95.19M 95.19M 58.42M 80.48M 54.96M 15.97M 15.97M 15.97M 15.97M 15.97M 15.97M 15.97M 15.97M 15.97M 10.21M 361.07K 6.88M 10.21M
EPS (Basic)
-0.09 -0.05 -0.06 -0.22 -0.04 -0.23 -0.42 -0.37 -0.31 -0.4 -0.22 -0.24 -0.25 -0.22 -0.3 -0.21 -0.73 -0.09
EPS (Diluted)
-0.09 -0.05 -0.06 -0.22 -0.04 -0.23 -0.42 -0.37 -0.31 -0.4 -0.22 -0.24 -0.25 -0.22 -0.3 -0.21 -0.73 -0.09
EBITDA
-8.82M -5.53M -4.31M -18.7M -3.09M -3.82M -6.93M -6.18M -5.29M -6.66M -3.88M -4.04M -3.5M -3.44M -3.09M -1.57M -1.94M -840K
EBIT
-8.83M -5.53M -4.31M -18.7M -3.09M -3.82M -6.93M -6.18M -5.29M -6.67M -3.88M -4.05M -3.51M -3.44M -3.09M -1.57M -1.94M -840K
Depreciation & Amortization
4.07K 4.05K 2.93K 2.81K 2.57K 2.57K 2.57K 3.09K 3.19K 3.19K 3.19K 3.19K 2.88K n/a n/a n/a 1.94M 840.32K